Atlas Trials

Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm

Clinical trial NCT00234507 · COMPLETED

Trial details

NCT number
NCT00234507
Sponsor
Ipsen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Blepharospasm
Start date
2003-01-01
Primary completion
2004-05-25
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.